journavx vertex - Search News

Vertex Stock Jumps

Hosted on MSN · 4h

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

BioPharma Dive · 17h

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

MassLive · 37m

FDA approves new type of non-addictive painkiller from Boston drug company

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.

FDA approves first new non-opioid painkiller in decades, and it's from a MA company.

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

1h

Vertex Pharmaceuticals Shares Are Up Today: What's Going On?

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...

3h

What's Happening With VRTX Stock?

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results